JPRN-UMIN000021505
Completed
未知
The study for determining the drug resposible for perioperative anaphylaxis by using skin test and flow cytometry - The study for determining the drug resposible for perioperative anaphylaxis
Saiseikai Maebshi Hospital0 sites4 target enrollmentMarch 25, 2016
ConditionsPerioperative anaphylaxis
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Perioperative anaphylaxis
- Sponsor
- Saiseikai Maebshi Hospital
- Enrollment
- 4
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\)The pregnant woman /The patient who has a possibility of pregnancy 2\)The patient taking beta blocker 3\)The patient taking steroid 4\)The patient to whom a doctor judged inappropriate for participating in this study
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
The study for determining the drug resposible for perioperative anaphylaxis by using skin test and flow cytometryPerioperative anaphylaxisJPRN-UMIN000015751Gunma University Hospital, Department of Anesthesiology8
Active, not recruiting
Phase 1
Prospective study to assess the emergence of drug resistance to oseltamivir following treatment of acute influenza A among children - Oseltamivir resistance studyInfluenza AEUCTR2005-005239-80-GBniversity Hospitals Leicester, Leicester General Hospital100
Completed
Not Applicable
Clinical Pharmacological Study to Investigate the Effects of Mucosta Ophthalmic Suspension UD2% on Ocular Surface Cells in Patients with Dry EyeDry eyeJPRN-UMIN000022629Otsuka Pharmaceutical Co., Ltd.15
Active, not recruiting
Not Applicable
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage FormsEUCTR2008-006986-10-GBGlaxoSmithKline Consumer Healthcare
Active, not recruiting
Not Applicable
A Study to Assess the Pharmacologic Equivalence of Two Orlistat Dosage FormsEUCTR2007-004797-79-GBGlaxoSmithKline Consumer Healthcare